Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Ocular Side Effects Linked to Ovarian Cancer Drug
A recent study presented at the American Academy of Ophthalmology (AAO) meeting in Chicago has identified significant ocular side effects associated with mirvetuximab soravtansine (Elahere), a drug approved for ovarian cancer treatment. The research, conducted by Stanford University, highlights the…
New Imaging Boosts Geographic Atrophy Diagnosis
At the 2024 American Academy of Ophthalmology (AAO) meeting in Chicago, Dr. SriniVas R. Sadda discussed the evolving landscape of imaging technologies for diagnosing geographic atrophy (GA). While traditional methods like flash color fundus photography have been the gold standard…
SLT Beats Medications in Glaucoma – AAO 2024
A recent retrospective analysis of the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial data demonstrated that selective laser trabeculoplasty (SLT) as a first-line treatment significantly outperforms glaucoma medications in reducing the rate of visual field (VF) loss. This study,…
Reducing the Carbon Footprint of Intravitreal Injections
Adopting specific treatment protocols, minimizing travel for patients and staff, and reducing unnecessary use of personal protective equipment (PPE) can significantly decrease the carbon footprint of intravitreal injections. This topic was discussed in detail by Redmer van Leeuwen, MD, PhD,…
Study: Aromatherapy Eases Post-Surgery Anxiety and Pain
A recent study suggests that aromatherapy may effectively reduce postoperative anxiety and pain in patients undergoing oculoplastic procedures under monitored anesthetic sedation. Published in Ophthalmic Plastic and Reconstructive Surgery, this randomized controlled trial highlights the potential of aromatherapy as an…
Study Links Socioeconomics to Severe Retinal Detachment
A recent study indicates that patients living in socioeconomically deprived neighborhoods are more likely to present with severe rhegmatogenous retinal detachment (RRD), a serious eye condition that can lead to vision loss if not treated promptly. Adverse social determinants of…
AI Retinal Scanning for Cardiovascular Risk Assessment
A collaborative team of international researchers is exploring the potential of artificial intelligence (AI) in ophthalmology to assess cardiovascular risks by analyzing retinal images. The study has been detailed in a position paper published in the Asia-Pacific Journal of Ophthalmology.…
OneSight and WHO Partner on SPECS 2030
The OneSight EssilorLuxottica Foundation has entered a strategic partnership with the World Health Organization (WHO) as a global collaborator in the SPECS 2030 initiative. This alliance aims to expedite progress toward achieving the first global target for effective refractive error…
Global Myopia Surge in Children Predicted to Hit 740M by 2050
A new analysis published in the British Journal of Ophthalmology reveals that nearly one in three children and teens worldwide is expected to be affected by myopia by 2050, translating to over 740 million cases. This trend reflects a significant…
Ocular Therapeutix Progresses Phase 3 OTX-TKI Trial
Ocular Therapeutix has announced that over 300 patients have been randomized in the SOL-1 Phase 3 trial for OTX-TKI (AXPAXLI, axitinib intravitreal implant). This marks a critical milestone in the development of the first registrational trial for OTX-TKI as a…